Skip to main content
Viatris

Viatris to Host Webinar: The Power of Partnership to Address Antimicrobial Resistance

Biofilm and Infected Wounds
November 1, 2023


PITTSBURGH, PA - (Oct. 30, 2023) – Viatris Inc. (NASDAQ: VTRS), a health care company, announced today it is hosting The Power of Partnership to Address Antimicrobial Resistance (AMR), a Nasdaq webinar that will air on Tuesday, November 14, 2023 at 9 am ET.

AMR is a significant threat to global health and economic development. As the progression of AMR renders antibiotics less effective, common infections, such as wound infections, urinary tract infections, and pneumonia can increasingly be associated with severe complications and increased risk of death. AMR is a major driver of death globally, potentially accounting for more deaths than HIV/AIDS and malaria worldwide.

The World Health Organization estimates that the number of deaths due to AMR could rise to 10 million people a year by 2050 under the most alarming scenario if no action is taken. No one company or entity can tackle the issue alone. Partnerships and collaborations are critical to tackling the problem together.

Moderated by Erika Satterwhite, Head of Global Policy at Viatris, the discussion will include Melissa Gong Mitchell, Secretariat Lead for the AMR Industry Alliance, and Dr. Yehoda Martei, Assistant Professor of Medicine, and the Vice Chief of Diversity, Inclusion and Health Equity in the Division of Hematology-Oncology at the University of Pennsylvania.

Register here to join this this free webinar sponsored by Viatris Inc.  

About Viatris

Viatris Inc. (NASDAQ: VTRS) is a  health care company that combines generics and brands to address health care needs globally.  Headquartered in the US, with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com.